Two recovery tools, two different jobs in over-40s

Recovery from high-intensity training tends to slow with age, and athletes past 40 are often the most motivated to try interventions such as cold therapy or ischaemic preconditioning. The trouble is that recovery methods get compared as if they do the same job, when they may act on entirely different domains — blood flow, muscle damage markers, neuromuscular output or simply how recovered you feel. This trial set out to compare ischaemic preconditioning, cold compression and passive recovery head to head after a plyometric fatigue protocol in this older recreational population, with tissue perfusion nominated in advance as the primary endpoint.

Sixty recreational CrossFit athletes aged 40 or older were randomly allocated 1:1:1 to ischaemic preconditioning, cold compression or a passive-recovery control in a randomised repeated-measures trial. Outcomes were measured at baseline, immediately after exercise, and at 24, 48 and 72 hours plus 7 and 14 days. Tissue perfusion was the primary confirmatory endpoint. Creatine kinase, reactive strength index, Total Quality Recovery, Borg CR10 and lactate dehydrogenase were secondary outcomes, which the authors explicitly framed as supportive and hypothesis-generating rather than confirmatory. The trial was prospectively registered.

Group-by-time interactions were significant across outcomes (all p < 0.001). At 14 days, resting superficial cutaneous and subcutaneous perfusion was higher than control by 1.94 PU with ischaemic preconditioning (g = 2.98) and by 0.88 PU with cold compression (g = 1.35). Creatine kinase at 72 hours was lower in both intervention arms than control, with geometric mean ratios of 0.58 and 0.55. Cold compression additionally improved reactive strength index at 72 hours by 0.15 m/s versus control and Total Quality Recovery at 14 days by 3.28 points. The overall pattern was domain-specific rather than one method winning outright.

This adds a direct three-way comparison in an under-studied age group and pushes back on the idea of a single best recovery modality. The authors are unusually careful about interpretation, stating the perfusion findings should not be read as evidence of endothelial function, nitric-oxide-mediated vascular adaptation or deep muscle perfusion — a caution worth carrying forward given how often such measures get over-extrapolated. Only the perfusion endpoint was confirmatory, so the creatine kinase, strength and perceived-recovery results are best treated as leads. Whether these short-term signals translate into better training outcomes over months is untested.

The practical takeaway is that these two methods appear to do different things rather than compete for the same benefit. If perceived recovery and getting explosive qualities back within a few days is the priority, cold compression came out looking more useful here; ischaemic preconditioning's clearest signal was in surface blood flow, whose functional meaning the authors deliberately do not claim. All of this comes from a two-week trial in 60 people, so it is a reason to be curious rather than a settled protocol. Nothing here says either method is necessary.